Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants - PubMed (original) (raw)
Clinical Trial
Longitudinal relation between endogenous testosterone and cardiovascular disease risk factors in middle-aged men. A 13-year follow-up of former Multiple Risk Factor Intervention Trial participants
J M Zmuda et al. Am J Epidemiol. 1997.
Abstract
The present study examined lifestyle and behavioral correlates of the change in total testosterone over 13 years in 66 men aged 41-61 years who were former participants of the Multiple Risk Factor Intervention Trial (MRFIT) at the Pittsburgh, Pennsylvania, center. The authors also determined in these men if changes in total testosterone are related to changes in cardiovascular disease risk factors. The mean total testosterone level was 751 (standard deviation, 248) ng/dl at baseline and decreased by 41 (standard deviation, 314) ng/dl during follow-up. The correlation between measures was r = 0.44 (p < 0.001). In multivariate analysis, higher type A coronary-prone behavior score, greater pack-years of cigarette smoking, and the MRFIT special intervention group were associated with larger decreases in total testosterone. Age, body weight, weight change, leisure time activity level, and alcohol intake were not related to the change in total testosterone. The decrease in endogenous testosterone was associated with an increase in triglycerides and a decrease in high density lipoprotein cholesterol in multivariate analysis controlling for obesity and other lifestyle covariates. There was little relation between change in testosterone and change in total and low density lipoprotein cholesterol or blood pressure. This longitudinal study confirms a gradual decline in total testosterone levels with advancing age in older men and provides evidence that lifestyle and psychosocial factors are related to this decline. Decreases in endogenous testosterone levels with age in men are associated with potentially unfavorable changes in triglycerides and high density lipoprotein cholesterol.
Similar articles
- Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24-45 years. The Cardiovascular Risk in Young Finns Study.
Firtser S, Juonala M, Magnussen CG, Jula A, Loo BM, Marniemi J, Viikari JS, Toppari J, Perheentupa A, Hutri-Kähönen N, Raitakari OT. Firtser S, et al. Atherosclerosis. 2012 May;222(1):257-62. doi: 10.1016/j.atherosclerosis.2012.02.020. Epub 2012 Feb 21. Atherosclerosis. 2012. PMID: 22420889 - Low serum testosterone in men is inversely associated with non-fasting serum triglycerides: the Tromsø study.
Agledahl I, Skjaerpe PA, Hansen JB, Svartberg J. Agledahl I, et al. Nutr Metab Cardiovasc Dis. 2008 May;18(4):256-62. doi: 10.1016/j.numecd.2007.01.014. Epub 2007 Jun 8. Nutr Metab Cardiovasc Dis. 2008. PMID: 17560771 - Life-style correlates of risk factor change in young adults: an eight-year study of coronary heart disease risk factors in the Framingham offspring.
Hubert HB, Eaker ED, Garrison RJ, Castelli WP. Hubert HB, et al. Am J Epidemiol. 1987 May;125(5):812-31. doi: 10.1093/oxfordjournals.aje.a114598. Am J Epidemiol. 1987. PMID: 3565356 - Behavioral Counseling to Promote a Healthful Diet and Physical Activity for Cardiovascular Disease Prevention in Adults Without Known Cardiovascular Disease Risk Factors: Updated Systematic Review for the U.S. Preventive Services Task Force [Internet].
Patnode CD, Evans CV, Senger CA, Redmond N, Lin JS. Patnode CD, et al. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Jul. Report No.: 15-05222-EF-1. Rockville (MD): Agency for Healthcare Research and Quality (US); 2017 Jul. Report No.: 15-05222-EF-1. PMID: 29364620 Free Books & Documents. Review. - Endogenous Testosterone Levels and Cardiovascular Risk: Meta-Analysis of Observational Studies.
Corona G, Rastrelli G, Di Pasquale G, Sforza A, Mannucci E, Maggi M. Corona G, et al. J Sex Med. 2018 Sep;15(9):1260-1271. doi: 10.1016/j.jsxm.2018.06.012. Epub 2018 Aug 23. J Sex Med. 2018. PMID: 30145097 Review.
Cited by
- Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence.
Cheung KK, Luk AO, So WY, Ma RC, Kong AP, Chow FC, Chan JC. Cheung KK, et al. J Diabetes Investig. 2015 Mar;6(2):112-23. doi: 10.1111/jdi.12288. Epub 2014 Nov 3. J Diabetes Investig. 2015. PMID: 25802717 Free PMC article. Review. - Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III.
Mondul AM, Selvin E, Rohrmann S, Menke A, Feinleib M, Kanarek N, Rifai N, Dobs AS, Platz EA. Mondul AM, et al. Cancer Causes Control. 2010 Oct;21(10):1575-83. doi: 10.1007/s10552-010-9586-6. Epub 2010 May 29. Cancer Causes Control. 2010. PMID: 20512526 Free PMC article. - Effect of exercise on serum sex hormones in men: a 12-month randomized clinical trial.
Hawkins VN, Foster-Schubert K, Chubak J, Sorensen B, Ulrich CM, Stancyzk FZ, Plymate S, Stanford J, White E, Potter JD, McTiernan A. Hawkins VN, et al. Med Sci Sports Exerc. 2008 Feb;40(2):223-33. doi: 10.1249/mss.0b013e31815bbba9. Med Sci Sports Exerc. 2008. PMID: 18202581 Free PMC article. Clinical Trial. - Aging and sex hormones in males.
Decaroli MC, Rochira V. Decaroli MC, et al. Virulence. 2017 Jul 4;8(5):545-570. doi: 10.1080/21505594.2016.1259053. Epub 2016 Nov 10. Virulence. 2017. PMID: 27831823 Free PMC article. Review. - Effect of Topical Estrogen in the Mangement of Traumatic Facial Wounds.
Ghazizadeh Hashemi SA, Barati B, Mohammadi H, Saeidi M, Bahreini A, Kiani MA. Ghazizadeh Hashemi SA, et al. Iran J Otorhinolaryngol. 2016 Jan;28(84):45-9. Iran J Otorhinolaryngol. 2016. PMID: 26878003 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical